Cargando…
The Challenge of Compliance and Persistence: Focus on Ulcerative Colitis
BACKGROUND: Non-adherence to therapy is a widespread problem, with typical adherence rates for prescribed medications being approximately 50%. An estimated 20% to 50% of patients with ulcerative colitis (UC)do not take their medications as prescribed, resulting in higher disease recurrencerates and...
Autores principales: | Kane, Sunanda V., Brixner, Diana, Rubin, David T., Sewitch, Maida J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438168/ https://www.ncbi.nlm.nih.gov/pubmed/18240888 http://dx.doi.org/10.18553/jmcp.2008.14.S1-A.1a |
Ejemplares similares
-
Optimizing use of 5-ASA in the treatment of ulcerative colitis: Focus on patient compliance and adherence
por: Bernick, Steven J, et al.
Publicado: (2010) -
Mild-to-Moderate Ulcerative Colitis: Your Role in Patient Compliance and Health Care Costs
por: Tindall, William N., et al.
Publicado: (2007) -
Efficacy of JAK inhibitors in Ulcerative Colitis
por: Ferrante, Marc, et al.
Publicado: (2020) -
JAK Inhibitors Safety in Ulcerative Colitis: Practical Implications
por: Agrawal, Manasi, et al.
Publicado: (2020) -
Current approaches to the management of new-onset ulcerative colitis
por: Marchioni Beery, Renée, et al.
Publicado: (2014)